Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
5.39
+0.19 (3.65%)
At close: Dec 5, 2025, 4:00 PM EST
5.42
+0.03 (0.46%)
After-hours: Dec 5, 2025, 7:24 PM EST
Vanda Pharmaceuticals Employees
Vanda Pharmaceuticals had 368 employees as of December 31, 2024. The number of employees increased by 165 or 81.28% compared to the previous year.
Employees
368
Change (1Y)
165
Growth (1Y)
81.28%
Revenue / Employee
$576,288
Profits / Employee
-$228,802
Market Cap
318.53M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VNDA News
- 1 day ago - FDA Lifts Partial Clinical Hold on Tradipitant for Motion Sickness - PRNewsWire
- 6 days ago - Should You Invest in This Under-the-Radar Weight Loss Stock? - The Motley Fool
- 8 days ago - Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness - PRNewsWire
- 15 days ago - Vanda Pharmaceuticals: Commercial Execution Meets Pipeline Optionality - Seeking Alpha
- 18 days ago - Side Effects From Wegovy? This Vanda Pharmaceuticals' Drug Halves Vomiting In Patients - Benzinga
- 18 days ago - Vanda Pharmaceuticals Reports Positive Results for Tradipitant in Preventing GLP-1 Induced Nausea and Vomiting - PRNewsWire
- 4 weeks ago - Vanda Pharmaceuticals Announces Participation in the Stifel 2025 Healthcare Conference - PRNewsWire
- 5 weeks ago - Vanda Pharmaceuticals Inc. (VNDA) Q3 2025 Earnings Call Transcript - Seeking Alpha